Enhancement of growth of virulent strains of Escherichia coli by interleukin-1
- PMID: 1833820
- DOI: 10.1126/science.1833820
Enhancement of growth of virulent strains of Escherichia coli by interleukin-1
Abstract
Interleukin-1 (IL-1) is a polypeptide cytokine that mediates many physiological responses to infection and inflammation and is a growth factor for certain mammalian cells. Virulent and avirulent clinical isolates of Escherichia coli were grown in culture media in the presence of human IL-1. IL-1 beta, but not tumor necrosis factor or IL-4, enhanced the growth of virulent, but not avirulent, E. coli. This enhancement was blocked by the IL-1 receptor antagonist (IL-1ra). Radiolabeled IL-1 bound to virulent but not avirulent E. coli in a specific and saturable fashion; IL-1ra inhibited this binding. Thus, human IL-1 may recognize a functional IL-1-like receptor structure on virulent E. coli and may be a virulence factor for bacterial pathogenicity.
Comment in
-
IL-1 beta and Escherichia coli.Science. 1992 Dec 4;258(5088):1562-3. doi: 10.1126/science.1455239. Science. 1992. PMID: 1455239 No abstract available.
Similar articles
-
A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.FASEB J. 1991 Mar 1;5(3):338-43. doi: 10.1096/fasebj.5.3.1825816. FASEB J. 1991. PMID: 1825816
-
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.J Clin Invest. 1992 May;89(5):1551-7. doi: 10.1172/JCI115748. J Clin Invest. 1992. PMID: 1533231 Free PMC article.
-
Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.J Exp Med. 1991 Apr 1;173(4):931-9. doi: 10.1084/jem.173.4.931. J Exp Med. 1991. PMID: 1826128 Free PMC article.
-
IL-1ra: properties and uses of an interleukin-1 receptor antagonist.Agents Actions Suppl. 1991;35:41-9. Agents Actions Suppl. 1991. PMID: 1838233 Review. No abstract available.
-
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.J Clin Invest. 1991 Nov;88(5):1445-51. doi: 10.1172/JCI115453. J Clin Invest. 1991. PMID: 1834696 Free PMC article. Review.
Cited by
-
The bacterial microbiota in inflammatory lung diseases.Clin Immunol. 2015 Aug;159(2):177-82. doi: 10.1016/j.clim.2015.05.022. Epub 2015 Jun 26. Clin Immunol. 2015. PMID: 26122174 Free PMC article. Review.
-
Host surface ectonucleotidase-CD73 and the opportunistic pathogen, Porphyromonas gingivalis, cross-modulation underlies a new homeostatic mechanism for chronic bacterial survival in human epithelial cells.Virulence. 2020 Dec;11(1):414-429. doi: 10.1080/21505594.2020.1763061. Virulence. 2020. PMID: 32419582 Free PMC article.
-
Polarised interleukin 8 secretion by HT 29/19A cells.Gut. 1994 Mar;35(3):338-42. doi: 10.1136/gut.35.3.338. Gut. 1994. PMID: 8150343 Free PMC article.
-
Gene Networks Underlying the Resistance of Bifidobacterium longum to Inflammatory Factors.Front Immunol. 2020 Nov 16;11:595877. doi: 10.3389/fimmu.2020.595877. eCollection 2020. Front Immunol. 2020. PMID: 33304352 Free PMC article.
-
Molecules-mediated bidirectional interactions between microbes and human cells.NPJ Biofilms Microbiomes. 2025 Mar 4;11(1):38. doi: 10.1038/s41522-025-00657-2. NPJ Biofilms Microbiomes. 2025. PMID: 40038292 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources